v3.26.1
Segment Information - Schedule of Segment Reporting Information (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
General and administrative:    
Stock-based compensation $ 1,286 $ 1,386
Intangible asset impairment charge 67,808 0
Fair value adjustment for contingent consideration (64,330) 1,924
Total operating expenses 14,590 14,858
Loss from operations (14,590) (14,858)
Fair value adjustment for warrants (31,116) 0
Net income (loss) 35,912 (15,030)
Reportable Segment    
Research and development:    
Personnel 1,914 1,320
Stock-based compensation 542 435
Clinical and contract manufacturing 3,600 6,727
Other 789 (337)
General and administrative:    
Personnel 1,335 1,727
Stock-based compensation 744 951
Consulting and professional costs 1,558 1,466
Other 630 645
Intangible asset impairment charge 67,808 0
Fair value adjustment for contingent consideration (64,330) 1,924
Total operating expenses 14,590 14,858
Loss from operations (14,590) (14,858)
Fair value adjustment for debt 12,168 (444)
Fair value adjustment for warrants 31,116 0
Other segment items 7,218 272
Net income (loss) $ 35,912 $ (15,030)